Results 51 to 60 of about 61,588 (194)

Analysis of hemorrhagic cystitis and BK viremia in children after hematopoietic stem cell transplantation

open access: yesIndian Journal of Transplantation, 2022
Purpose: Hemorrhagic cystitis (HC) which occurs in 9%–31% of recipients after hematopoietic stem cell transplantation (HSCT) is an important cause of morbidity and mortality.
Ayça Koca Yozgat   +7 more
doaj   +1 more source

Detection of Bk Polyomavirus Antigen in Patients with Acute Lymphoblastic Leukemia

open access: yesDiyala Journal of Medicine, 2023
Background: BK polyomavirus  that is acquired in early childhood as BKPyV is near ubiquitous in adults with a seroprevalence of >80%, it has been found as the main cause of hemorrhagic cystitis in hematopoietic stem cell transplantation patients, due to
Safa H Ali ,   +3 more
doaj   +1 more source

BK Virus in Cancer Development

open access: yesCurrent Issues in Pharmacy and Medical Sciences, 2018
Polyomavirus (PyV) was discovered by accident in 1950 in the course of describing an infectious factor causing multiple tumours in rodents. The term is derived from two Greek words: poly (many) and oma (tumour).
Pasternak Justyna   +2 more
doaj   +1 more source

The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation

open access: yesTransplantation
BK polyomavirus (BKPyV) remains a significant challenge after kidney transplantation. International experts reviewed current evidence and updated recommendations according to Grading of Recommendations, Assessment, Development, and Evaluations (GRADE ...
C. Kotton   +16 more
semanticscholar   +1 more source

BK polyomavirus—pathogen, paradigm and puzzle

open access: yesNephrology Dialysis Transplantation, 2019
AbstractBK virus is a polyomavirus with seroprevalence rates of 80% in adults. Infection is usually acquired during childhood, and the virus is benign or pathologic depending on immune status. The virus reactivates in immunodeficiency states, mostly among transplant (either kidney or bone marrow) recipients.
Suman Krishna Kotla   +3 more
openaire   +2 more sources

Evaluation of polyomavirus BK reactivation in lupus patients who underwent kidney transplantation

open access: yesMicrobiologia Medica, 2012
Background. A pathogenic role for polyomavirus BK in systemic lupus erythematosus (SLE) has been proposed, however no study evaluated the occurrence of BK replication in renal transplant recipients according to the underlying disease leading to ...
Cristina Costa   +9 more
doaj   +1 more source

Taking the Scenic Route: Polyomaviruses Utilize Multiple Pathways to Reach the Same Destination

open access: yesViruses, 2020
Members of the Polyomaviridae family differ in their host range, pathogenesis, and disease severity. To date, some of the most studied polyomaviruses include human JC, BK, and Merkel cell polyomavirus and non-human subspecies murine and simian virus 40 ...
Colleen L. Mayberry, Melissa S. Maginnis
doaj   +1 more source

Control of Archetype BK Polyomavirus MicroRNA Expression

open access: yesJournal of Virology, 2020
The BK polyomavirus (BKPyV) miRNA plays an important role in regulating viral large-T-antigen expression and limiting the replication of archetype BKPyV, suggesting that the miRNA regulates BKPyV persistence. However, how miRNA expression is regulated is poorly understood.
Wei Zou   +5 more
openaire   +3 more sources

Role of BK Virus CTLs in the Treatment of BK Virus–Associated Nephropathy in Kidney‐Transplant and Hematopoietic Cell Transplant Recipients

open access: yesTransplant Infectious Disease, EarlyView.
Third‐party, BK virus‐specific cytotoxic T lymphocytes (CTLs) were safe and effective in reducing viremia in kidney and stem cell transplant recipients with BK virus nephropathy. However, they did not improve kidney function. Earlier administration may be more beneficial before nephropathy and irreversible damage occur.
Amanda Olson   +18 more
wiley   +1 more source

A randomized, placebo‐controlled, dose‐escalation phase I/II multicenter trial of low‐dose cidofovir for BK polyomavirus nephropathy

open access: yesTransplant Infectious Disease
BK polyomavirus‐associated nephropathy (BKPyVAN) is an important cause of allograft dysfunction and failure in kidney transplant recipients (KTRs) and there are no proven effective treatments. Case reports and in vitro data support the potential activity
Hannah Imlay   +11 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy